CD19 and leukemia: The Nalm-6/fLuc and Raji/fLuc xenograft models are useful models that are still commonly used for comparative evaluation of new designs of CD19 CAR-T cells targeting leukemias and lymphomas generated after viral gene delivery or by gene editing (54, 78).